FDA Issues Letters to Manufacturers of FDA-Regulated Products Regarding Bovine-Derived Materials

Summary

The Food and Drug Administration (FDA) has issued four letters to manufacturers of FDA-regulated products requesting that they avoid using bovine-derived materials from certain cattle due to concerns over bovine spongiform encephalopathy (BSE).